Instil Bio (UK) Limited

Research and experimental development on biotechnology · Macclesfield

ActiveUnited KingdomIncorporated 2008Private Limited Company

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-12-31

IXBRL · 121 source facts · 18 selected values

Validation findings

XBRL valid

Reporting period: 2025-01-01 to 2025-12-31
Extraction status: complete
Numeric facts: 66
Documents processed: 1
XBRL standards validation: valid
Filing-profile validation: invalid
Parser: arelle 2.44.4
Taxonomy: FRS-102-2026-01-01.xsd
Currency: GBP
Source identifier: Prod223_4317_06709883_20251231
Source archive: Accounts_Bulk_Data-2026-09-29.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-12-31

IXBRL · 163 source facts · 24 selected values

Validation findings

XBRL valid

Reporting period: 2024-01-01 to 2024-12-31
Extraction status: complete
Numeric facts: 97
Documents processed: 1
XBRL standards validation: valid
Filing-profile validation: invalid
Parser: arelle 2.44.4
Taxonomy: FRS-102-2024-01-01.xsd
Currency: GBP
Source identifier: Prod224_2509_06709883_20241231
Source archive: Accounts_Monthly_Data-September2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-12-31

IXBRL · 248 source facts · 22 selected values

Not assessed

legacy record

Reporting period: 2023-01-01 to 2023-12-31
Extraction status: Legacy / not assessed
Numeric facts: 155
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2024-01-01.xsd
Currency: GBP
Source identifier: Prod224_3200_06709883_20231231
Source archive: Accounts_Monthly_Data-December2024.zip

Accounts to 2020-02-29

IXBRL · 106 source facts · 23 selected values

Not assessed

legacy record

Reporting period: 2019-10-01 to 2020-02-29
Extraction status: Legacy / not assessed
Numeric facts: 66
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2019-01-01.xsd
Currency: GBP
Source identifier: Prod224_0087_06709883_20200229
Source archive: Accounts_Monthly_Data-February2021.zip

Accounts to 2019-09-30

IXBRL · 92 source facts · 22 selected values

Not assessed

legacy record

Reporting period: 2018-10-01 to 2019-09-30
Extraction status: Legacy / not assessed
Numeric facts: 51
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2014-09-01.xsd
Currency: GBP
Source identifier: Prod224_0074_06709883_20190930
Source archive: Accounts_Monthly_Data-January2020.zip

Accounts to 2018-09-30

IXBRL · 96 source facts · 22 selected values

Not assessed

legacy record

Reporting period: 2017-10-01 to 2018-09-30
Extraction status: Legacy / not assessed
Numeric facts: 56
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2014-09-01.xsd
Currency: GBP
Source identifier: Prod224_0067_06709883_20180930
Source archive: Accounts_Monthly_Data-June2019.zip

Accounts to 2017-09-30

IXBRL · 97 source facts · 22 selected values

Not assessed

legacy record

Reporting period: 2016-10-01 to 2017-09-30
Extraction status: Legacy / not assessed
Numeric facts: 57
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2014-09-01.xsd
Currency: GBP
Source identifier: Prod224_0054_06709883_20170930
Source archive: Accounts_Monthly_Data-May2018.zip

Accounts to 2016-09-30

IXBRL · 63 source facts · 22 selected values

Not assessed

legacy record

Reporting period: 2015-10-01 to 2016-09-30
Extraction status: Legacy / not assessed
Numeric facts: 43
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-full-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_0043_06709883_20160930
Source archive: Accounts_Monthly_Data-June2017.zip

Accounts to 2015-09-30

IXBRL · 61 source facts · 22 selected values

Not assessed

legacy record

Reporting period: 2014-10-01 to 2015-09-30
Extraction status: Legacy / not assessed
Numeric facts: 42
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-full-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_0031_06709883_20150930
Source archive: Accounts_Monthly_Data-June2016.zip

Accounts to 2014-09-30

IXBRL · 57 source facts · 20 selected values

Not assessed

legacy record

Reporting period: 2013-10-01 to 2014-09-30
Extraction status: Legacy / not assessed
Numeric facts: 38
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-full-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_0019_06709883_20140930
Source archive: Accounts_Monthly_Data-June2015.zip

Accounts to 2013-09-30

IXBRL · 57 source facts · 20 selected values

Not assessed

legacy record

Reporting period: 2012-10-01 to 2013-09-30
Extraction status: Legacy / not assessed
Numeric facts: 38
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-full-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_0007_06709883_20130930
Source archive: Accounts_Monthly_Data-June2014.zip

Accounts to 2012-09-30

IXBRL · 42 source facts · 16 selected values

Not assessed

legacy record

Reporting period: 2011-10-01 to 2012-09-30
Extraction status: Legacy / not assessed
Numeric facts: 24
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-main-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_9991_06709883_20120930
Source archive: Accounts_Monthly_Data-June2013.zip

Accounts to 2011-09-30

XBRL · 25 source facts · 6 selected values

Not assessed

legacy record

Reporting period: — to —
Extraction status: Legacy / not assessed
Numeric facts: 8
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-ae-2008-04-06.xsd
Currency: GBP
Source identifier: Prod224_9979_06709883_20110930
Source archive: Accounts_Monthly_Data-June2012.zip

Accounts to 2010-09-30

IXBRL · 26 source facts · 6 selected values

Not assessed

legacy record

Reporting period: 2009-10-01 to 2010-09-30
Extraction status: Legacy / not assessed
Numeric facts: 10
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-main-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_9968_06709883_20100930
Source archive: Accounts_Monthly_Data-July2011.zip

Accounts to 2009-09-30

XBRL · 25 source facts · 3 selected values

Not assessed

legacy record

Reporting period: — to —
Extraction status: Legacy / not assessed
Numeric facts: 10
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-ae-2008-04-06.xsd
Currency: GBP
Source identifier: Prod224_9955_06709883_20090930
Source archive: Accounts_Monthly_Data-June2010.zip

Registered details

06709883

Status: Active
Type: Private Limited Company
Incorporated: 2008-09-29
Jurisdiction: —
Registered office: ALDERLEY PARK BLOCK 19, CONGLETON ROAD, MACCLESFIELD, SK10 4TF, ENGLAND

Classification

2 SIC codes

7211086900

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

16 matched grants

MW-ATTC - Runway

Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 16 other participants

£0

awarded

Orbsen Therapeutics UK Ltd£311,900

University Hospitals Birmingham NHS Foundation Trustlead£237,425

Velindre University NHS Trust£170,333

University of Birmingham£110,243

Nottingham University Hospitals NHS Trust£96,264

Birmingham Women'S And Children'S Hospital Charity£73,262

University Hospitals Bristol NHS Foundation Trust£67,412

University Hospitals of Leicester NHS Trust£67,412

Fourplus Immersive Ltd£50,000

Thermo Electron Limited£44,752

Global Life Sciences Solutions Operations UK Ltd£33,125

Aston University£17,919

World Courier Management Limited£5,237

Cellular Therapeutics Ltd£0

Ixaka Limited£0

Miltenyi Biotec Limited£0

Trakcel Limited£0

A coordinated strategy to scale-up advanced therapies for patient in Manchester

Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 11 other participants

£499,773

awarded

The University of Manchester£560,476

Instil Bio (UK) Limited£499,773

Manchester University NHS Foundation Trust£270,594

The Christie NHS Foundation Trustlead£252,199

Aptus Clinical Limited£125,413

Global Life Sciences Solutions Operations UK Ltd£26,257

The Christie Pathology Partnership LLP£24,803

AgenTus Therapeutics Ltd£0

Astrazeneca UK Limited£0

Datatrial Limited£0

Formedix Limited£0

Sheffield Teaching Hospitals NHS Foundation Trust£0

Standard Approach to atMP tissue ColLEction (Sample)

Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 7 other participants

£17,770

awarded

Cryogatt Systems Limited£183,531

University of Birmingham£160,324

The Christie NHS Foundation Trustlead£47,536

Autolus Limited£30,000

Scottish National Blood Transfusion Service£19,146

Instil Bio (UK) Limited£17,770

Global Life Sciences Solutions Operations UK Ltd£5,040

Orbsen Therapeutics UK Ltd£0

A coordinated strategy to scale-up advanced therapies for patient in Manchester

ISCF · Centres · 2021-03-31 – 2022-03-30 · with 12 other participants

£1,759,515

whole project

The Christie NHS Foundation TrustleadAgentus Therapeutics LtdAptus Clinical LimitedAstrazeneca UK LimitedChaucer Group LimitedDatatrial Limited Formedix Limited Global Life Sciences Solutions Operations UK LtdInstil Bio (UK) LimitedManchester University NHS Foundation TrustSheffield Teaching Hospitals NHS Foundation TrustThe Christie Pathology Partnership LLP The University Of Manchester

Standard Approach to atMP tissue ColLEction (Sample)

ISCF · Centres · 2021-03-31 – 2022-03-30 · with 7 other participants

£463,347

whole project

The Christie NHS Foundation TrustleadAutolus Limited Cryogatt Systems Limited Global Life Sciences Solutions Operations UK LtdInstil Bio (UK) LimitedOrbsen Therapeutics UK LtdScottish National Blood Transfusion ServiceUniversity Of Birmingham

Manchester Metropolitan University and Instil Bio (UK) Limited

Innovate UK · Knowledge Transfer Partnership · 2020-02-01 – 2023-11-30 · with 1 other participant

Manchester Metropolitan Universitylead£200,725

Instil Bio (UK) Limited—

Evaluation of Tumour Infiltrating Lymphocytes as a Therapy in Advanced Ovarian CancerLead

Innovate UK · Collaborative R&D · 2018-12-01 – 2022-08-31

£2,685,958

awarded

Standard Approach to atMP tissue ColLEction (Sample)

Innovate UK · Collaborative R&D · 2018-12-01 – 2022-03-31 · with 9 other participants

£240,003

awarded

Scottish National Blood Transfusion Service£406,800

Autolus Limited£349,001

The Christie NHS Foundation Trustlead£301,526

NHS Blood and Transplant£249,802

Cellular Therapeutics Ltd£240,003

Asymptote Limited£222,306

Guy's and St Thomas' NHS Foundation Trust£117,265

The Newcastle upon Tyne Hospitals NHS Foundation Trust£110,193

Trakcel Limited£105,079

Manchester University NHS Foundation Trust£15,293

CellFlow - Chemical-Free Cell Isolation for Commercial-Scale Cell Therapy Manufacturing

Innovate UK · Collaborative R&D · 2018-03-01 – 2020-08-31 · with 3 other participants

£98,843

awarded

Labxero Limitedlead£348,560

University of Cambridge£207,480

Cellular Therapeutics Ltd£98,843

Cell Therapy Catapult Limited£51,464

Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC)

Innovate UK · Collaborative R&D · 2018-03-01 – 2022-03-31 · with 12 other participants

£676,155

awarded

University of Birmingham£1,851,945

Velindre NHS Trust£1,699,023

University Hospitals Birmingham NHS Foundation Trustlead£1,583,239

Orbsen Therapeutics UK Ltd£1,026,906

Instil Bio (UK) Limited£676,155

Trakcel Limited£542,350

Asymptote Limited£386,775

Ixaka Limited£332,414

NHS Blood and Transplant£190,938

Nottingham Uni Hospitals NHS Trust£156,772

Thermo Electron Limited£107,312

World Courier Logistics (UK) Limited£74,764

Aston University£0

Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC)

ISCF · Collaborative R&D · 2018-03-01 – 2022-03-30 · with 12 other participants

£8,628,593

whole project

University Hospitals Birmingham NHS Foundation TrustleadAston University Asymptote LimitedInstil Bio (UK) LimitedIxaka LimitedNHS Blood And TransplantNottingham Uni Hospitals NHS TrustOrbsen Therapeutics UK Ltd Thermo Electron Limited Trakcel LimitedUniversity Of BirminghamVelindre NHS TrustWorld Courier Logistics (UK) Limited

A coordinated strategy to scale-up advanced therapies for patients in Manchester

Innovate UK · Collaborative R&D · 2018-03-01 – 2022-04-30 · with 12 other participants

£1,109,717

awarded

The Christie NHS Foundation Trustlead£1,997,573

The University of Manchester£1,178,943

Manchester University NHS Foundation Trust£1,141,375

Cellular Therapeutics Ltd£1,109,717

Asymptote Limited£624,914

Aptus Clinical Limited£406,552

The Christie Pathology Partnership LLP£404,585

Datatrial Limited£336,249

Formedix Limited£309,873

Chaucer Group Limited£51,337

AgenTus Therapeutics Ltd£0

Astrazeneca PLC£0

Northern Care Alliance NHS Foundation Trust£0

CoStAR (Costimulatory Antigen Receptors)Lead

Innovate UK · Feasibility Studies · 2018-02-01 – 2019-01-31

£67,034

awarded

genTIL: Generation of a commercially viable Tumour Infiltrating Lymphocyte (TIL) therapyLead

Innovate UK · Collaborative R&D · 2017-08-01 – 2020-07-31 · with 1 other participant

£506,224

awarded

Cellular Therapeutics Ltdlead£506,224

Asymptote Limited£311,545

SEAMLESS: Second generation Adoptive cell therapy using MoLEcular growth SwitcheSssLead

Innovate UK · Collaborative R&D · 2017-07-01 – 2019-06-30

£188,783

awarded

miFACTS: Microfluidic system for Flexible Automated Cell Transduction and Selection

Innovate UK · Collaborative R&D · 2015-10-01 – 2018-09-30 · with 2 other participants

£29,727

awarded

Cell Therapy Catapult Limited£712,358

Sphere Fluidics Limitedlead£339,556

Cellular Therapeutics Ltd£29,727